Tanja Vollmer Selected Research

Tanja Vollmer Research Topics

7	Infections 01/2022 - 04/2009
7	Endocarditis 01/2018 - 06/2008
3	COVID-19 01/2022 - 07/2020
1	Malaria 10/2021
1	Reinfection 01/2021
1	Vesicular Stomatitis 07/2020
1	Hepatitis E 01/2018
1	Inflammation (Inflammations) 01/2014
1	Hematologic Neoplasms (Hematological Malignancy) 12/2006

4	Immunoglobulin G (IgG)IBA 01/2022 - 09/2016
3	AntibodiesIBA 01/2021 - 09/2016
2	VaccinesIBA 01/2022 - 07/2020
2	Immunoglobulin A (IgA)IBA 01/2021 - 09/2016
2	RNA (Ribonucleic Acid)IBA 01/2018 - 09/2016
2	Biomarkers (Surrogate Marker)IBA 09/2009 - 02/2009
2	lipopolysaccharide-binding proteinIBA 09/2009 - 02/2009
1	BNT162 VaccineIBA 01/2022
1	ChAdOx1 nCoV-19IBA 01/2022
1	Neutralizing AntibodiesIBA 07/2020
1	Proteins (Proteins, Gene)FDA Link 07/2020
1	CollagenIBA 01/2018
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2018
1	Glutamate DehydrogenaseIBA 09/2016
1	Alanine (L-Alanine)FDA Link 09/2016
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 09/2016
1	BilirubinIBA 09/2016
1	EnzymesIBA 09/2016
1	Immunoglobulin M (IgM)IBA 09/2016
1	Immunoglobulin IsotypesIBA 09/2016
1	CytokinesIBA 01/2014
1	Ribosomal DNA (rDNA)IBA 05/2010
1	Virulence Factors (Pathogenicity Factors)IBA 03/2010
1	locked nucleic acidIBA 04/2009
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 12/2006

1	Blood Transfusion (Blood Transfusions) 10/2021
1	Critical Care (Surgical Intensive Care) 06/2008
1	Artificial Respiration (Mechanical Ventilation) 06/2008